Performance of a new vascular xeno prosthesis

Area of Science:

• Biomaterials Science
• Vascular Surgery
• Regenerative Medicine

Background:

• Autologous saphenous veins remain the gold standard for small-diameter vascular prostheses (<6 mm).
• Existing synthetic options like polytetrafluoroethylene (PTFE) have limitations in narrow arterial applications.
• A need exists for improved prosthetic materials for peripheral and coronary artery bypass grafting.

Purpose of the Study:

• To evaluate the in vitro and in vivo performance of a novel glutaraldehyde-stabilized bovine ureter vascular prosthesis (Flonova, 4 mm diameter).
• To compare the Flonova prosthesis against the autologous saphenous vein and PTFE prostheses.
• To assess the potential of bovine ureter grafts for small-diameter arterial reconstructions.

Main Methods:

• In vitro analysis included modifications of American National Standards for Vascular Prostheses.
• Blood compatibility assessed via platelet consumption in an artificial circulation.
• Heparin uptake quantified using tritiated heparin.
• In vivo evaluation utilized a canine bilateral femoral interposition model.

Main Results:

• Bovine ureter grafts exhibited adequate mural integrity and hemocompatible properties comparable to saphenous veins.
• In vivo patency rates were 62.5% for bovine ureter grafts versus 43.75% for PTFE grafts.
• Platelet consumption and heparin uptake indicated favorable blood compatibility for the bovine ureter material.

Conclusions:

• Glutaraldehyde-stabilized bovine ureter grafts demonstrate promising hemocompatibility and in vivo performance.
• These grafts show excellent potential for narrow diameter peripheral and coronary arterial bypass procedures.
• Further investigation of bovine ureter prostheses for small-diameter vascular applications is warranted.